Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Bioeq IP AG

02 3Genentech

03 16Novartis Pharmaceuticals Australia Pty Limited

04 4Novartis Pharmaceuticals Corporation

05 1Novartis South Africa (Pty) Ltd

06 3Samsung Bioepis

07 2Sandoz B2B

08 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ranibizumab

Brand Name : Ranivisio

Dosage Form : Inj L?s

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : LUCENTIS

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 125156

Regulatory Info :

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : LUCENTIS

Dosage Form : Injectable; Injection

Dosage Strength : 6MG/ML

Packaging :

Approval Date :

Application Number : 125156

Regulatory Info :

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : SUSVIMO

Dosage Form : SOLUTION;INJECTION

Dosage Strength : 100MG/ML

Packaging :

Approval Date :

Application Number : 761197

Regulatory Info :

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ranibizumab

Brand Name : Lucentis

Dosage Form : Inj L?s

Dosage Strength : 1.65mg/0.165ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ranibizumab

Brand Name : Lucentis

Dosage Form : Inj L?s

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : LUCENTIS

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging : 0.165ML

Approval Date :

Application Number : 2425629

Regulatory Info : Prescription

Registration Country : Canada

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : LUCENTIS

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging : 0.23ML

Approval Date :

Application Number : 2296810

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB-NUNA

Brand Name : BYOOVIZ

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 0.5MG(10MG/ML)

Packaging :

Approval Date :

Application Number : 761202

Regulatory Info :

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ranibizumab

Brand Name : Byooviz

Dosage Form : Inj Sol

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : BYOOVIZ

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 2525852

Regulatory Info : Prescription

Registration Country : Canada

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB-EQRN

Brand Name : CIMERLI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 0.3MG(6MG/ML)

Packaging :

Approval Date :

Application Number : 761165

Regulatory Info :

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB-EQRN

Brand Name : CIMERLI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 0.5MG(10MG/ML)

Packaging :

Approval Date :

Application Number : 761165

Regulatory Info :

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RANIBIZUMAB

Brand Name : RANOPTO

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 2542250

Regulatory Info : Prescription

Registration Country : Canada

blank

15

Novartis South Africa (Pty) Ltd

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
2024 ACI Convention
Not Confirmed

Ranibizumab

Brand Name : Lucentis® 10Mg/Ml Solution For Injection

Dosage Form : INJ

Dosage Strength : 10mg/ml

Packaging : 0.23X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

16

Novartis Pharmaceuticals Australia ...

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
2024 ACI Convention
Not Confirmed

ranibizumab

Brand Name : Lucentis

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

Novartis Pharmaceuticals Australia ...

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
2024 ACI Convention
Not Confirmed

ranibizumab

Brand Name : Lucentis

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

Novartis Pharmaceuticals Australia ...

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
2024 ACI Convention
Not Confirmed

ranibizumab

Brand Name : Lucentis

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

Novartis Pharmaceuticals Australia ...

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
2024 ACI Convention
Not Confirmed

ranibizumab

Brand Name : Lucentis

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

Novartis Pharmaceuticals Australia ...

Country
2024 ACI Convention
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
2024 ACI Convention
Not Confirmed

ranibizumab

Brand Name : Lucentis

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank